Pfizer's booth at the China International Import Expo in Shanghai, Nov. 7, 2024. [Photo by Wang Yiming/China.org.cn] Pfizer ...
While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...
The study compared the risk and cumulative incidence of requiring glaucoma surgery—such as minimally invasive surgery, ...
Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...
The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...
Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...
The U.S. Food and Drug Administration (FDA) announced the target action date of its review of the sNDA for VTAMA (tapinarof) cream, 1% has changed.
LEO Pharma has shared final results from a long-term extension study of its atopic dermatitis (AD) drug Adbry ...
ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.
The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...
Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback